Case 3: POETIC and ADAPT Trials in HR High-Risk Breast Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Case 3: POETIC and ADAPT Trials in HR High-Risk Breast Cancer | Targ…
Mar 14, 2022
targetedonc.com
Dr O’Shaughnessy on the Impetus for the ELEGANT Study in High-Risk Breast Cancer | OncLive
Dr O’Shaughnessy on the Impetus for the ELEGANT Study in High-Ri…
3 months ago
onclive.com
Dr. O'Shaughnessy on the Utility of Capivasertib in Targeting Akt in Breast Cancer | OncLive
Dr. O'Shaughnessy on the Utility of Capivasertib in Targeting Akt in Br…
Mar 9, 2020
onclive.com
Dr O’Shaughnessy on the Utility of the MammaPrint Assay in HR Breast Cancer | OncLive
2:35
Dr O’Shaughnessy on the Utility of the MammaPrint Assay in HR Brea…
8 months ago
onclive.com
The HER2-Positive Breast Cancer Landscape | CancerNetwork
The HER2-Positive Breast Cancer Landscape | CancerNetwork
Oct 7, 2022
cancernetwork.com
Dr O’Shaughnessy on Highly Anticipated Breast Cancer Data to Watch at ESMO 2025 | OncLive
0:56
Dr O’Shaughnessy on Highly Anticipated Breast Cancer Data to …
7 months ago
onclive.com
DESTINY-Breast04: T-DXd in HER2-Low Metastatic Breast Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
DESTINY-Breast04: T-DXd in HER2-Low Metastatic Breast Cancer | Ta…
Sep 11, 2023
targetedonc.com
2:02:17
HER2-Low and HER2-Ultralow Breast Cancer — A Roundtable Di…
32 viewsFeb 15, 2025
YouTubeResearch To Practice
2:00
After losing her mom to breast cancer, Amy Zicarelli faced her ow…
6 months ago
linkedin.com
1:00
Join us as we scrub in for a chat about the future of women’s canc…
151.2K viewsSep 25, 2023
FacebookMary Kay Global
1:56
Joyce O’Shaughnessy, MD: Treatment Goals for Patients With …
583 viewsMar 31, 2016
YouTubeTargeted Oncology
2:01
Dr. O'Shaughnessy Discusses New Developments in Molecular Profili…
105 viewsAug 27, 2015
YouTubeOncLive
2:28
Expert Discusses Promise of Abemaciclib for Breast Cancer Tre…
599 viewsMay 31, 2017
YouTubeTargeted Oncology
16:01
What is inflammatory breast cancer? Patient Jennifer Cordts ta…
14.6K viewsFeb 28, 2023
YouTubeWFAA
1:27
Case Summary and Optimisms for Future Advancements
24 viewsNov 26, 2018
YouTubeTargeted Oncology
2:10
Fact or Fiction w/Dr. O: Can exercise reduce your risk or recurrence of …
70 viewsFeb 21, 2021
YouTubebreastcancercanstick
1:03
Dr. O'Shaughnessy on the Future of TNBC Treatment
285 viewsSep 15, 2011
YouTubeOncLive
1:22
Dr. O'Shaughnessy on the Utility of Capivasertib in Targeting Akt in Br…
550 viewsMar 8, 2020
YouTubeOncLive
5:10
Treatment Factors & Trial Data to Support Emerging Therapies
32 viewsNov 26, 2018
YouTubeTargeted Oncology
1:09:24
Raising the Bar in HR+/HER2- Early Breast Cancer: CDK4 and 6 Inhibit…
2.5K viewsApr 4, 2022
YouTubePeerView Oncology
Dr. O'Shaughnessy on the Future of TNBC Treatment | OncLive
Sep 15, 2011
onclive.com
2:40
Local oncologist making medical history, leading clinical trials
Mar 12, 2025
nbcdfw.com
4:28
A Stage II HER2+ Breast Cancer Patient
399 viewsMar 31, 2020
YouTubeTargeted Oncology
1:28
Dr. O'Shaughnessy on Precision Medicine in Triple Negative Breas…
473 viewsSep 13, 2016
YouTubeOncLive
26:08
Metastatic Hormone Positive Breast Cancer | 2023 KU Breast Cancer Y…
5.2K viewsMar 24, 2023
YouTubeTotal Health Oncology
3:05
Initial Case Impressions and Treatment Options
29 viewsNov 26, 2018
YouTubeTargeted Oncology
5:06
Factors in Deciding Treatment for HR+ Breast Cancer
231 viewsMay 3, 2018
YouTubeOncLive
Meeting an Unmet Need in the Treatment of Early Breast Cancer
Apr 24, 2023
medscape.com
1:52
Dr. O’Shaughnessy on the Utility of Tucatinib in the HER2+ Breast Can…
151 viewsAug 18, 2020
YouTubeOncLive
See more videos
Static thumbnail place holder